Slayback Pharma - Ownership and Business Overview

Life ScienceCompany

Slayback Pharma Ownership

Who owns Slayback Pharma?

Slayback Pharma is owned by Azurity Pharmaceuticals. It was acquired on September 27, 2023.

Was Slayback Pharma formerly PE-backed?

Yes. Slayback Pharma was formerly owned by 1 private investor.

Slayback Pharma Business Overview

Where is Slayback Pharma headquartered?

Slayback Pharma is headquartered in Princeton, New Jersey.

What sector is Slayback Pharma in?

Slayback Pharma is a life science company.

When was Slayback Pharma founded?

Slayback Pharma was founded in 2011.

Life Science M&A Summary in 2023

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2023. The largest life science acquisition in 2023 was Seagen - which was acquired by Pfizer for $43.0B.

Join Mergr to view all 204 acquisitions of life science companies in 2023, including 26 acquisitions by private equity firms, and 178 by strategics.

Slayback Pharma

Slayback Pharma LLC

301 Carnegie Center, Suite 303,
Princeton, New Jersey 08540
United States,
(609) 945 3443
www.slayback-pharma.com

Slayback Pharma is a specialty pharmaceutical company focused on developing, manufacturing, and sourcing complex generic pharmaceutical products, with a specific emphasis on complex injectables and other non-solid oral products. Slayback Pharma was founded in 2011 and is based in Princeton, New Jersey.


 Subscribe to unlock this and 208,055
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.